Literature DB >> 10573254

Tuberculosis management in Europe. Task Force of the European Respiratory Society (ERS), the World Health Organisation (WHO) and the International Union against Tuberculosis and Lung Disease (IUATLD) Europe Region.

G B Migliori1, M C Raviglione, T Schaberg, P D Davies, J P Zellweger, M Grzemska, T Mihaescu, L Clancy, L Casali.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10573254     DOI： 10.1183/09031936.99.14497899

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  18 in total

Review 1.  Tuberculosis in pregnancy and the puerperium.

Authors:  P Ormerod
Journal:  Thorax       Date:  2001-06       Impact factor: 9.139

2.  PharmGKB summary: isoniazid pathway, pharmacokinetics.

Authors:  Daniel J Klein; Sotiria Boukouvala; Ellen M McDonagh; Scott R Shuldiner; Nicola Laurieri; Caroline F Thorn; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2016-09       Impact factor: 2.089

3.  Comparative study using tuberculin from Cantacuzino Institute versus Statens Serum Institute.

Authors:  Cristian Cojocaru; Maria Panescu; Camelia Vasilescu; T Mihaescu
Journal:  Maedica (Buchar)       Date:  2010-01

Review 4.  Hepatotoxic effects of therapies for tuberculosis.

Authors:  Bahaa E Senousy; Sanaa I Belal; Peter V Draganov
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-08-31       Impact factor: 46.802

5.  PBPK Analysis to Study the Impact of Genetic Polymorphism of NAT2 on Drug-Drug Interaction Potential of Isoniazid.

Authors:  Ankit Balhara; Saranjit Singh
Journal:  Pharm Res       Date:  2021-09-13       Impact factor: 4.200

Review 6.  Revised guidelines for the diagnosis and control of tuberculosis: impact on management in the elderly.

Authors:  Paul Van den Brande
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

7.  Anti-tuberculosis drug-induced hepatitis in renal transplant patient with pulmonary and extra pulmonary tuberculosis.

Authors:  Zaher Al-Salmi
Journal:  Saudi Pharm J       Date:  2011-09-23       Impact factor: 4.330

Review 8.  Antitubercular therapy in patients with cirrhosis: challenges and options.

Authors:  Naveen Kumar; Chandan Kumar Kedarisetty; Sachin Kumar; Vikas Khillan; Shiv Kumar Sarin
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

9.  Opposing neural effects of naltrexone on food reward and aversion: implications for the treatment of obesity.

Authors:  Elizabeth Murray; Sietske Brouwer; Rob McCutcheon; Catherine J Harmer; Philip J Cowen; Ciara McCabe
Journal:  Psychopharmacology (Berl)       Date:  2014-04-25       Impact factor: 4.530

10.  Persistent high incidence of tuberculosis in immigrants in a low-incidence country.

Authors:  Troels Lillebaek; Ase B Andersen; Asger Dirksen; Else Smith; Lene T Skovgaard; Axel Kok-Jensen
Journal:  Emerg Infect Dis       Date:  2002-07       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.